NK cells enhance their cytotoxic capacity and cytokine production through co-stimulatory molecules like NKG2D and CD244, providing probably stronger tumor-specific targeting and cytotoxicity than CAR-T cells [66]. This evidence concerns the gene KLRK1 and neoplasm.